For years, a common belief in the cannabis community has been that CBD (cannabidiol) can mitigate or “buffer” the less desirable effects of THC (tetrahydrocannabinol), such as anxiety, paranoia, and memory impairment. However, a new study suggests that this may not be the case.
Researchers at University College London (UCL) conducted a double-blind, randomized trial to investigate whether CBD could indeed reduce the adverse effects of THC. The results, published recently, have challenged the long-held assumption that a higher CBD-to-THC ratio makes for a “safer” or more controlled experience.
The Study Details
The study involved 48 healthy volunteers, including both adolescents and adults. Each participant was given different variations of vaporized cannabis across separate sessions:
- A placebo
- A high-THC strain
- A strain with a high concentration of both THC and CBD (1:3 ratio)
Under medical supervision, participants were assessed for psychoactive effects, memory performance, and subjective feelings of being “high.”
Key Findings
The research team found no significant difference in the subjective “high” or the cognitive impairment experienced between the THC-only strain and the THC+CBD strain. Despite the high levels of CBD, the negative impacts of THC on memory and the level of intoxication remained consistent.
Dr. Will Lawn, the lead author of the study and a lecturer at King’s College London, noted that the results were surprising. “In contrast to what is commonly hypothesized in popular literature, CBD did not reduce the adverse effects of THC,” he stated.
Interestingly, the study also observed that when THC was paired with CBD, the concentration of THC in the participants’ blood was actually higher. While this didn’t translate to a more intense psychoactive effect in this trial, it suggests a complex pharmacokinetic interaction between the two cannabinoids.
Implications for Consumers
These findings suggest that consumers looking to avoid the anxiety or cognitive fog associated with THC may not be able to rely solely on CBD-rich strains to solve the problem. While CBD has many potential therapeutic benefits on its own, its role as a “safety net” for THC consumption is now being questioned.
Experts suggest that further research is needed to determine if much higher doses of CBD—higher than those typically found in commercial cannabis flower—might yield different results. For now, the study serves as a reminder that the relationship between cannabinoids is more complex than previously thought.
